Medtronic Korea said Thursday that it has signed a partnership with the Korean Society of Type 1 Diabetes to support people living with type 1 diabetes.
In addition to providing insulin pumps to help people with type 1 diabetes manage their blood sugar, Medtronic has signed an agreement with the organization to support various projects to support the lives of people with type 1 diabetes, the company added.
For instance, Medtronic Korea will provide insulin pumps and supplies for one year to adult type 1 diabetes patients aged 19 and older who were not covered by the insurance benefit expanded earlier this year. The recipients will receive all out-of-pocket expenses for insulin pumps and supplies for one year.
The company will also conduct a public campaign to dispel myths about type 1 diabetes and raise social awareness of the disease.
"We decided to partner with Medtronic Korea after considering what we can do to help Korean patients who do not have access to the latest technology despite the advancement of artificial pancreas systems around the world," Medtronic Korea Vice President and Managing Director Yoo Seung-rok said. "We will continue to work together with type 1 diabetes patients to realize Medtronic's mission of alleviating suffering, restoring health, and extending life for patients."
For more information on the Medtronic Insulin Pump Sponsorship Program, visit Sugar Tree (https://cafe.naver.com/t1d), the internet cafe of the Korean Society of Type 1 Diabetes, on the portal Naver.
Related articles
- Medtronic Korea to directly sell diabetes management devices
- MediThinQ, Medtronic to advance surgical technology with AR wearable Scopeye
- Kakao Healthcare launches AI-based mobile blood glucose management service 'PASTA'
- ‘Latest artificial pancreas system will change blood sugar treatment strategy for type 1 diabetes’
- EOFlow CEO addresses Medtronic acquisition fallout, lawsuit with Insulet in IR briefing
- Medtronic decides not to acquire Korean wearable insulin pump maker EOFlow due to US patent suit
- ‘Persistent underweight is dangerous for diabetics as heart failure risk soars’
- TAVI reduces medical cost significantly in Korean healthcare system, experts say
- Medtronic opens Korea's 1st robotic surgery research and training center in Osong
- Medtronic's drug-coated balloon for dialysis patients to be reimbursed in Korea starting May
